Kestrel

HOLEPS (Holmium Laser Enucleation of the Prostate)

South Tees Hospitals NHS Foundation Trust · published Fri 28 Nov 2025

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by ICS Operations T/A Xyla Elective Care in Nov 2025.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 6 different firms won this buyer's 3 awards for this kind of work in 2025.

From South Tees Hospitals NHS Foundation Trust's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The notice doesn't say where the documents are, but South Tees Hospitals NHS Foundation Trust's other tenders use Atamis. Register there (it's free) and look for this tender, or email the buyer's contact on the notice.

The notice as published

This agreement is for Holmium laser bladder enucleation prostate services to be undertaken on behalf of South Tees NHS FT. <br/><br/>Holmium laser bladder enucleation prostate (HoLEP) is the procedure used to treat benign prostatic hyperplasia (BPH, a non-cancerous enlargement of the prostate. Prostate tissue is removed to allow passing of urine.<br/><br/>This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using the most suitable provider process.<br/><br/>The estimated contract start date is 1st January 2026, the value of this will be £240,000.00 over the duration.